Development of a model that integrates inflammation and tissue injury to predict and mitigate the post-acute sequelae of COVID19
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40122C00051
- Awardee
-
Children's Hospital LOS Angeles UEI DVL1CMRMWRN9
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,275,305
Award facts
- Contract value 100% obligated
- $2,275,305.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 10 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $1,715,877 | |
| Original award | $559,428 |
About this award
This is a $2,275,305.00 definitive cost-no-fee contract awarded by the U.S. Food and Drug Administration (FDA) to Children's Hospital Los Angeles (CHLA) with a performance period through June 16, 2024. The contract is for the development of a model that integrates inflammation and tissue injury to predict and mitigate the post-acute sequelae of COVID-19. As prime contractor, CHLA has subcontracted portions of the work to the University of Southern California and the University of California, Los Angeles. CHLA is an experienced federal contractor, having received numerous prior awards from agencies like the National Institutes of Health, Department of Health and Human Services, and Department of Defense to conduct research and provide clinical services. This specific contract did not use a set-aside designation.
Quick answers
Who was awarded contract 75F40122C00051?
75F40122C00051 was awarded to Children's Hospital LOS Angeles by Food and Drug Administration (Department of Health and Human Services) on June 17, 2022.
How much is contract 75F40122C00051 worth?
The government has obligated $2,275,305 on 75F40122C00051.
Was contract 75F40122C00051 competed?
The extent of competition for 75F40122C00051 was full and open competition. The government received 10 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award